Susan E Bates

Susan E Bates

UNVERIFIED PROFILE

Are you Susan E Bates?   Register this Author

Register author
Susan E Bates

Susan E Bates

Publications by authors named "Susan E Bates"

Are you Susan E Bates?   Register this Author

100Publications

1747Reads

29Profile Views

A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide.

Semin Oncol 2019 Aug - Oct;46(4-5):351-361. Epub 2019 Nov 16.

James J. Peters Bronx Veterans Affairs Medical Center, Bronx, NY; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.11.004DOI Listing
January 2020

VA Cancer Research: A Legacy and A Future.

Semin Oncol 2019 Aug - Oct;46(4-5):305-307

Duke University, VA Medical Center in Durham, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.11.001DOI Listing
January 2020

Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical Dilemma.

Oncologist 2019 Oct 1. Epub 2019 Oct 1.

Division of Hematology/Oncology, Columbia University Irving Medical Center, New York New York, USA

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2019-0264DOI Listing
October 2019

Targeting Translation of mRNA as a Therapeutic Strategy in Cancer.

Curr Hematol Malig Rep 2019 Aug;14(4):219-227

Department of Medicine, Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-019-00530-yDOI Listing
August 2019

Publish or Perish v2.

Authors:
Susan E Bates

Oncologist 2019 Jun 7;24(6):723-724. Epub 2019 May 7.

Division of Hematology and Oncology, Department of Medicine, Columbia University Medical Center, New York New York, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656494PMC
June 2019

PD-1 Pandemonium at the American Association for Cancer Research Annual Meeting.

Authors:
Susan E Bates

Oncologist 2019 May;24(5):571-573

Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516112PMC
May 2019

Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor models.

Exp Cell Res 2019 Feb 21;375(2):106-112. Epub 2018 Dec 21.

Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, United States; Columbia University Medical Center, Division of Hematology/Oncology, New York, NY 10032, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2018.12.012DOI Listing
February 2019

Neoadjuvant Treatment for Pancreatic Cancer.

Semin Oncol 2019 Feb 28;46(1):19-27. Epub 2018 Dec 28.

The Division of Medical Oncology, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00937754183026
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2018.12.002DOI Listing
February 2019

Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes.

Semin Oncol 2019 Feb 26;46(1):83-99. Epub 2019 Jan 26.

Columbia University / New York Presbyterian Hospital and James J. Peters VA Medical Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.01.002DOI Listing
February 2019

Conflict of Interest: An Ethical Firestorm with Consequences for Cancer Research.

Oncologist 2018 12 23;23(12):1391-1393. Epub 2018 Oct 23.

Division of Hematology and Oncology, Department of Medicine, Columbia University Medical Center, New York New York, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292535PMC
December 2018

Entinostat finds a path: A new study elucidates effects of the histone deacetylase inhibitor on the immune system.

Cancer 2018 12 13;124(24):4597-4600. Epub 2018 Nov 13.

Division of Hematology and Oncology, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31766DOI Listing
December 2018

Revisiting the role of ABC transporters in multidrug-resistant cancer.

Nat Rev Cancer 2018 07;18(7):452-464

Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41568-018-0005-8
Publisher Site
http://dx.doi.org/10.1038/s41568-018-0005-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622180PMC
July 2018

Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.

J Clin Oncol 2018 06 18;36(16):1594-1602. Epub 2017 Dec 18.

Anish Thomas, Christophe E. Redon, Linda Sciuto, Emerson Padiernos, Min-Jung Lee, Akira Yuno, Sunmin Lee, Arun Rajan, Udayan Guha, Haobin Chen, Raffit Hassan, Christine C. Alewine, Eva Szabo, Seth M. Steinberg, James H. Doroshow, Mirit I. Aladjem, Jane B. Trepel, and Yves Pommier, National Cancer Institute, Bethesda; Jiuping Ji, Yiping Zhang, Lan Tran, William Yutzy, and Robert J. Kinders, Frederick National Laboratory for Cancer Research, Frederick, MD; and Susan E. Bates, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.6915DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978471PMC
June 2018

Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo.

Cancer Lett 2018 06 5;424:19-29. Epub 2018 Mar 5.

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2018.02.040DOI Listing
June 2018

Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 ( Expression with Class I Histone Deacetylase Inhibitors.

Clin Cancer Res 2018 04 1;24(8):1944-1953. Epub 2018 Feb 1.

Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-0443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899656PMC
April 2018

Refining Immunotherapy Approvals.

Authors:
Susan E Bates

Clin Cancer Res 2017 09;23(17):4948-4949

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-2025DOI Listing
September 2017

Reversal of ABCB1 mediated efflux by imatinib and nilotinib in cells expressing various transporter levels.

Chem Biol Interact 2017 Aug 13;273:171-179. Epub 2017 Jun 13.

Department of Anatomy, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc 77515, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cbi.2017.06.012DOI Listing
August 2017

Base Pairs to Populations.

Authors:
Susan E Bates

Clin Cancer Res 2017 06;23(11):2610

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2631DOI Listing
June 2017

Metabolic symbiosis in cancer and its therapeutic implication.

Semin Oncol 2017 06 10;44(3):233-234. Epub 2017 Oct 10.

Center for Lymphoid Malignancies, Department of Medicine Columbia University Medical Center, New York, NY; Division of Hematology and Oncology, Department of Medicine Columbia University Medical Center New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2017.09.001DOI Listing
June 2017

Pancreatic Cancer: Challenge and Inspiration.

Authors:
Susan E Bates

Clin Cancer Res 2017 04;23(7):1628

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2069DOI Listing
April 2017

Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma".

Clin Cancer Res 2017 Apr;23(7):1629-1637

HonorHealth, Scottsdale, Arizona and TGen, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2070DOI Listing
April 2017

Current challenges in the management of breast cancer brain metastases.

Semin Oncol 2017 04 8;44(2):85-100. Epub 2017 Jul 8.

Columbia University Medical Center, NY; J.J. Peters VA Medical Center, Bronx, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2017.06.006DOI Listing
April 2017

Too Many Journals.

Authors:
Susan E Bates

Oncologist 2017 02 10;22(2):126-128. Epub 2017 Feb 10.

Columbia University Medical Center, New York, New York, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330714PMC
February 2017

Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.

Lancet Oncol 2017 01 13;18(1):143-154. Epub 2016 Dec 13.

Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30633-7DOI Listing
January 2017

Multiple Myeloma: Multiplying Therapies.

Authors:
Susan E Bates

Clin Cancer Res 2016 11;22(22):5418

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0624DOI Listing
November 2016

Endocrine Cancers: Defying the Paradigms.

Authors:
Susan E Bates

Clin Cancer Res 2016 10;22(20):4980

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0366DOI Listing
October 2016

Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.

Clin Cancer Res 2016 Oct;22(20):4989-5000

James J. Peters Veterans Administration Medical Center, Bronx, New York. Division of Medical Oncology, Department of Medicine, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1570DOI Listing
October 2016

Romidepsin Therapy Over 5 Years in a Clinical Setting-Real-world Experience.

JAMA Oncol 2016 Jun;2(6):794-5

Division of Cutaneous Oncology, Department of Dermatology, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0072DOI Listing
June 2016

Phase I Testing: 60 Years in the Making.

Authors:
Susan E Bates

Clin Cancer Res 2016 06;22(11):2612

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2642DOI Listing
June 2016

Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer.

Oncologist 2016 05 22;21(5):523-6. Epub 2016 Apr 22.

New York Presbyterian Hospital, New York, New York, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861375PMC
May 2016

Clinical trials: New drug for pancreatic cancer highlights the dual effect of regulatory approvals.

Nat Rev Clin Oncol 2016 Apr 23;13(4):205-6. Epub 2016 Feb 23.

Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center, Herbert Irving Pavilion, 9th Floor, 161 Fort Washington Avenue, New York, New York 10032, USA; and the James J. Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, New York 10468, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.22DOI Listing
April 2016

Disruptive Immunology.

Authors:
Susan E Bates

Clin Cancer Res 2016 Apr;22(8):1844

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1850DOI Listing
April 2016

Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.

Oncologist 2016 Mar 17;21(3):261-8. Epub 2016 Feb 17.

Medical Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786361PMC
March 2016

How Do Cancer Cells Die?

Authors:
Susan E Bates

Clin Cancer Res 2015 Nov;21(22):5014

Columbia University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1203DOI Listing
November 2015

Histone deacetylase inhibitors modulate KATP subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis.

Front Pharmacol 2015 13;6:168. Epub 2015 Aug 13.

Department of Anatomy, Physiology and Genetics, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2015.00168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534802PMC
August 2015

Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma.

Clin Cancer Res 2015 May 12;21(9):2096-106. Epub 2015 Feb 12.

Center for Lymphoid Malignancies, Columbia University Medical Center, New York, New York. Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York. Department of Medicine, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2249DOI Listing
May 2015

CCR 20th Anniversary Commentary: Expanding the Epigenetic Therapeutic Portfolio.

Clin Cancer Res 2015 May;21(10):2195-7

Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2555DOI Listing
May 2015

Quit early, quit often.

Authors:
Susan E Bates

Clin Cancer Res 2015 May;21(10):2212

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2749DOI Listing
May 2015

Targeting RAS: The Elusive Prize.

Authors:
Susan E Bates

Clin Cancer Res 2015 Apr;21(8):1796

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2664DOI Listing
April 2015

Central nervous system metastasis from breast cancer.

Authors:
Susan E Bates

Oncologist 2015 Jan 26;20(1):3-4. Epub 2014 Dec 26.

Center for Cancer Research, National Cancer Institute, National Institutes for Health, Bethesda, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0469DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294618PMC
January 2015

The lymphoma medicine cabinet.

Authors:
Susan E Bates

Clin Cancer Res 2014 Oct;20(20):5172

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-1257DOI Listing
October 2014

Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.

Clin Cancer Res 2014 Oct;20(20):5240-54

Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2020DOI Listing
October 2014

Therapies with diverse mechanisms of action kill cells by a similar exponential process in advanced cancers.

Cancer Res 2014 Sep;74(17):4653-62

Medical Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/74/17/4653.full.pd
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-14-0420DOI Listing
September 2014

Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance.

Int J Biochem Cell Biol 2014 Jun 12;51:111-9. Epub 2014 Apr 12.

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2014.03.026DOI Listing
June 2014

Clinical trial results: a clinical trial bazaar!

Oncologist 2014 Apr 25;19(4):313-4. Epub 2014 Mar 25.

Center for Cancer Research, National Cancer Institute, National Institutes for Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983835PMC
April 2014

Developing precision medicine in a global world.

Clin Cancer Res 2014 Mar;20(6):1419-27

Authors' Affiliations: Merck Research Laboratories, North Wales, Pennsylvania; Friends of Cancer Research, Arlington, Virginia; NorthShore University Health System Pathology and Laboratory Medicine, Evanston, Illinois; and Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0091DOI Listing
March 2014

On masterpieces and breast cancer research.

Authors:
Susan E Bates

Clin Cancer Res 2013 Dec;19(23):6352

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2847DOI Listing
December 2013

Overlapping substrate and inhibitor specificity of human and murine ABCG2.

Drug Metab Dispos 2013 Oct 18;41(10):1805-12. Epub 2013 Jul 18.

Laboratory of Cell Biology (J.B., M.D.H., M.M.G.), Cancer Therapeutics Branch (R.W.R., S.E.B.), Collaborative Protein Technology Resource (M.A.H., J.-Q.C.), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.113.053140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781367PMC
October 2013

A sea change in melanoma.

Authors:
Susan E Bates

Clin Cancer Res 2013 Oct;19(19):5282

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2219DOI Listing
October 2013

Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.

Front Oncol 2013 Oct 9;3:261. Epub 2013 Oct 9.

University of Zagreb, School of Medicine, Department for Respiratory Diseases Jordanovac, University Hospital Center Zagreb , Zagreb , Croatia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793201PMC
October 2013

PFS: the endpoint we love and love to hate.

Authors:
Susan E Bates

Clin Cancer Res 2013 May;19(10):2606

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0869DOI Listing
May 2013

Waking the immune system at last.

Authors:
Susan E Bates

Clin Cancer Res 2013 Mar;19(5):996

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0274DOI Listing
March 2013

Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration.

Cancer Biol Ther 2013 Feb 28;14(2):175-83. Epub 2012 Nov 28.

Medical Oncology Branch, National Cancer Institute; Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.22957DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571999PMC
February 2013

Reinventing cancer cell metabolism.

Authors:
Susan E Bates

Clin Cancer Res 2012 Oct;18(20):5536

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2884DOI Listing
October 2012

Drug resistance: still a daunting challenge to the successful treatment of AML.

Drug Resist Updat 2012 Feb-Apr;15(1-2):62-9. Epub 2012 Mar 11.

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4255, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drup.2012.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348380PMC
August 2012

Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.

Drug Resist Updat 2012 Feb-Apr;15(1-2):50-61. Epub 2012 Mar 29.

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drup.2012.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680361PMC
August 2012

Pancreatic cancer: steps in the right direction.

Authors:
Susan E Bates

Clin Cancer Res 2012 Aug;18(16):4248

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2162DOI Listing
August 2012

Progress in pediatric cancer.

Authors:
Susan E Bates

Clin Cancer Res 2012 May;18(10):2734

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1014DOI Listing
May 2012

Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma.

Clin J Oncol Nurs 2012 Apr;16(2):195-204

Medical Oncology Branch at Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1188/12.CJON.195-204DOI Listing
April 2012

Molecular diagnostics: are we there yet?

Authors:
Susan E Bates

Clin Cancer Res 2012 Mar;18(6):1514

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2207DOI Listing
March 2012

A millennium goal for cancer.

Authors:
Susan E Bates

Clin Cancer Res 2012 Feb;18(3):606

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3229DOI Listing
February 2012

EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.

Cancer Res 2012 Jan 8;72(1):315-24. Epub 2011 Nov 8.

Cell & Molecular Biology Section, National Cancer Institute, NIH, Bethesda, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-0961DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487161PMC
January 2012

On drug development, chance, and the prepared mind.

Authors:
Susan E Bates

Clin Cancer Res 2012 Jan;18(1):22

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2908DOI Listing
January 2012

Drug development: portals of discovery.

Clin Cancer Res 2012 Jan;18(1):23-32

Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1001DOI Listing
January 2012

Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.

Discov Med 2012 Jan;13(68):19-34

Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006110PMC
January 2012

Histone deacetylase inhibitors: emerging mechanisms of resistance.

Mol Pharm 2011 Dec 7;8(6):2021-31. Epub 2011 Oct 7.

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/mp200329fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230675PMC
December 2011

Gout, genetics and ABC transporters.

F1000 Biol Rep 2011 1;3:23. Epub 2011 Nov 1.

Molecular therapeutics section, Medical Oncology Branch, National Cancer Institute, Building 10 - Room 13N248, National Institutes of Health 9000 Rockville Pike, Bethesda, MD 20892 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3410/B3-23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206739PMC
November 2011

Antibody conjugates: the future is now.

Authors:
Susan E Bates

Clin Cancer Res 2011 Oct;17(20):6388

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2199DOI Listing
October 2011

The controversial role of ABC transporters in clinical oncology.

Essays Biochem 2011 Sep;50(1):209-32

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, 9000 Rockville Pike, Building 10, Room 13N240, Bethesda, MD 20892, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/bse0500209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944313PMC
September 2011